Role of Microenvironmental-Derived AXII in Myeloma Bone Disease An Exploratory Model

G
G. David Roodman, MD, PhD

Primary Investigator

Overview

The purpose of this research is to learn if substances that cause bone destruction are increased in multiple myeloma patient's blood or bone marrow.

Description

The purpose of this research is to learn if substances that cause bone destruction are increased in multiple myeloma patient's blood or bone marrow.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Multiple Myeloma
  • Age: Between 18 Years - 65 Years
  • Gender: All

Inclusion Criteria
Diagnosed with multiple myeloma

Exclusion Criteria
Currently pregnant or breastfeeding
Have a history of bleeding conditions
Additional Information:
Participants may be paid for their participation.

Updated on 31 Aug 2023. Study ID: 1203008199 (IUCRO-0381)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center